Optimind Pharma Corp.
CNQ: OMND.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David Goodman
- Headquarters
- Toronto, Canada
- IPO year
- 2022
- Market cap
- CA$515.7K
- Website
- https://optimindpharma.com
Loading OMND…
Loading profile data…Frequently asked questions about OMND
What does Optimind Pharma Corp. (OMND.CN) do?
Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clini...
Where does OMND.CN trade?
Optimind Pharma Corp. (OMND.CN) trades on the Canadian Securities Exchange.
What sector is OMND.CN in?
Optimind Pharma Corp. (OMND.CN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Optimind Pharma Corp.?
David Goodman is the chief executive officer of Optimind Pharma Corp. (OMND.CN).
Where is Optimind Pharma Corp. headquartered?
Optimind Pharma Corp. is headquartered in Canada.
Does OMND.CN pay a dividend?
Optimind Pharma Corp. (OMND.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OMND.CN go public?
Optimind Pharma Corp. (OMND.CN) completed its initial public offering in 2022.